See more : Fifth Third Bancorp (0IM1.L) Income Statement Analysis – Financial Results
Complete financial analysis of Alpa Laboratories Limited (ALPA.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alpa Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Lincoln National Corporation (LNC-PD) Income Statement Analysis – Financial Results
- Funding Circle Holdings plc (FDCHF) Income Statement Analysis – Financial Results
- Orchid Island Capital, Inc. (ORC) Income Statement Analysis – Financial Results
- ScandBook Holding AB (publ) (SBOK.ST) Income Statement Analysis – Financial Results
- Contact Gold Corp. (CGOLF) Income Statement Analysis – Financial Results
Alpa Laboratories Limited (ALPA.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.alpalabs.in
About Alpa Laboratories Limited
Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.09B | 924.36M | 1.11B | 964.14M | 848.70M | 764.22M | 613.19M | 656.81M | 535.90M | 573.94M | 567.08M | 561.09M | 551.30M | 819.54M | 934.37M | 1.22B |
| Cost of Revenue | 898.50M | 631.76M | 760.87M | 647.56M | 552.75M | 530.90M | 398.33M | 418.55M | 307.19M | 400.10M | 366.46M | 403.19M | 431.24M | 728.84M | 844.95M | 1.13B |
| Gross Profit | 188.90M | 292.60M | 344.26M | 316.58M | 295.95M | 233.32M | 214.86M | 238.27M | 228.71M | 173.84M | 200.63M | 157.89M | 120.06M | 90.71M | 89.41M | 89.75M |
| Gross Profit Ratio | 17.37% | 31.65% | 31.15% | 32.84% | 34.87% | 30.53% | 35.04% | 36.28% | 42.68% | 30.29% | 35.38% | 28.14% | 21.78% | 11.07% | 9.57% | 7.38% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 15.72M | 10.77M | 17.23M | 22.03M | 20.78M | 18.82M | 10.19M | 13.40M | 76.55M | 85.22M | 6.19M | 6.05M | 0.00 | 45.32M | 46.61M | 42.65M |
| Selling & Marketing | 59.49M | 51.61M | 57.93M | 44.88M | 53.43M | 50.04M | 41.18M | 9.09M | 2.92M | 2.85M | 28.50M | 19.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 127.38M | 62.38M | 75.16M | 66.91M | 74.20M | 68.86M | 51.37M | 22.49M | 79.46M | 88.08M | 134.67M | 105.02M | 0.00 | 45.32M | 46.61M | 42.65M |
| Other Expenses | 0.00 | 99.33M | 1.48M | 516.00K | 1.06M | 467.00K | 71.00K | 1.79M | 747.00K | 1.08M | 150.00K | 234.00K | 5.22K | 18.16M | 31.39M | 36.10M |
| Operating Expenses | 127.38M | 230.30M | 248.85M | 219.42M | 250.81M | 237.84M | 194.49M | 202.85M | 145.52M | 200.23M | 234.46M | 173.77M | 104.39M | 63.48M | 78.00M | 78.74M |
| Cost & Expenses | 1.01B | 862.06M | 1.01B | 866.97M | 803.56M | 768.74M | 592.83M | 621.40M | 452.71M | 600.33M | 600.92M | 576.96M | 535.63M | 792.31M | 922.95M | 1.21B |
| Interest Income | 23.18M | 10.45M | 14.82M | 6.54M | 5.34M | 29.06M | 32.07M | 44.60M | 40.51M | 25.58M | 585.00K | 423.00K | 262.70K | -621.01K | 0.00 | 22.66M |
| Interest Expense | 3.59M | 2.23M | 1.07M | 261.00K | 951.00K | 4.77M | 7.81M | 16.32M | 12.75M | 15.01M | 21.22M | 19.45M | 12.42M | 2.01M | 0.00 | 19.55M |
| Depreciation & Amortization | 19.55M | 13.29M | 16.57M | 12.29M | 31.65M | 31.18M | 31.50M | 27.80M | 8.31M | 60.66M | 90.59M | 47.29M | 10.03M | 11.10M | 11.74M | 12.96M |
| EBITDA | 229.96M | 174.43M | 214.31M | 130.29M | 61.67M | 64.84M | 88.40M | 101.30M | 120.15M | 50.57M | 62.30M | 31.42M | 25.70M | 17.42M | 36.32M | 23.96M |
| EBITDA Ratio | 21.15% | 18.92% | 11.78% | 11.67% | 12.12% | 9.23% | 15.63% | 17.71% | 26.43% | 10.46% | 10.01% | 5.60% | 4.66% | 5.14% | 2.24% | 2.09% |
| Operating Income | 61.52M | 67.62M | 90.06M | 74.05M | 47.12M | 2.40M | 184.55M | 35.42M | 83.19M | -26.40M | -33.83M | -15.88M | 15.67M | 27.23M | 11.42M | 11.01M |
| Operating Income Ratio | 5.66% | 7.31% | 8.15% | 7.68% | 5.55% | 0.31% | 30.10% | 5.39% | 15.52% | -4.60% | -5.97% | -2.83% | 2.84% | 3.32% | 1.22% | 0.90% |
| Total Other Income/Expenses | 145.31M | 91.29M | 100.21M | 43.18M | -16.17M | 32.52M | 13.04M | -17.97M | 14.18M | -624.00K | -16.32M | -16.26M | -7.32M | -16.41M | -10.22M | 494.00K |
| Income Before Tax | 206.82M | 159.40M | 195.62M | 107.86M | 29.08M | 25.39M | 46.20M | 38.61M | 97.37M | -27.12M | -49.51M | -32.13M | 8.36M | 10.82M | 10.15M | 11.50M |
| Income Before Tax Ratio | 19.02% | 17.24% | 17.70% | 11.19% | 3.43% | 3.32% | 7.53% | 5.88% | 18.17% | -4.72% | -8.73% | -5.73% | 1.52% | 1.32% | 1.09% | 0.94% |
| Income Tax Expense | 39.06M | 33.08M | 54.70M | 35.39M | 10.54M | 17.45M | 18.40M | 29.30M | 28.91M | -13.14M | 2.04M | 11.55M | 3.07M | 1.78M | 2.18M | 7.71M |
| Net Income | 167.77M | 126.32M | 140.92M | 72.47M | 18.53M | 7.94M | 27.90M | 9.31M | 68.46M | -13.98M | -51.55M | -43.68M | 5.28M | 9.04M | 7.97M | 3.79M |
| Net Income Ratio | 15.43% | 13.67% | 12.75% | 7.52% | 2.18% | 1.04% | 4.55% | 1.42% | 12.77% | -2.44% | -9.09% | -7.78% | 0.96% | 1.10% | 0.85% | 0.31% |
| EPS | 8.01 | 5.98 | 6.70 | 3.44 | 0.88 | 0.35 | 1.33 | 1.20 | 3.25 | -0.66 | -2.45 | -2.08 | 0.25 | 0.43 | 0.38 | 0.18 |
| EPS Diluted | 8.01 | 5.98 | 6.70 | 3.44 | 0.88 | 0.35 | 1.33 | 1.20 | 3.25 | -0.66 | -2.45 | -2.08 | 0.25 | 0.43 | 0.38 | 0.18 |
| Weighted Avg Shares Out | 20.94M | 21.04M | 21.04M | 21.04M | 21.04M | 22.48M | 21.04M | 21.04M | 21.04M | 21.18M | 21.04M | 21.00M | 21.04M | 21.04M | 21.04M | 21.04M |
| Weighted Avg Shares Out (Dil) | 20.94M | 21.04M | 21.04M | 21.04M | 21.04M | 22.48M | 21.04M | 21.04M | 21.06M | 21.18M | 21.04M | 21.00M | 21.04M | 21.04M | 21.04M | 21.04M |
Source: https://incomestatements.info
Category: Stock Reports